Molecular properties
- Formula
- C16H18FN3O3
- Molar mass
- 319.34 g·mol−1
- Exact mass
- 319.1332 Da
- 9
- PubChem CID
- 4539
Molecule record
1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
C16H18FN3O3
319.34 g/mol
Loading structure
Functional groups
Alkane / alkyl carbon
Aromatic ring
Aryl halide
Carboxylic acid
Secondary amine
Tertiary amine
Physical properties
No source-backed physical properties are curated for this molecule yet.
Common names and synonyms
- 1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
- 1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure
- 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
- 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
- 3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
- 70458-96-7
- AM-715
- Baccidal
Show all 24 synonyms
- CHEBI:100246
- Chibroxin
- DTXCID5017680
- DTXSID7037680
- Fulgram
- MK-366
- N0F8P22L1P
- NFLX
- NSC-757250
- Norfloxacine
- Norfloxacino
- Norfloxacinum
- Noroxin
- Sebercim
- Utinor
- norfloxacin
Structure identifiers
- Canonical SMILES
- CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21
- Isomeric SMILES
- CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
- InChI
- InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23)
- InChIKey
- OGJPXUAPXNRGGI-UHFFFAOYSA-N
- PubChem CID
- 4539
Spectroscopy
Tabs appear only for spectra stored with clear provenance.
No redistributable or simulated spectroscopy record is attached yet.
Simulated NMR
On-demand educational prediction for 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; not experimental data.
Simulated EI mass spectrum
On-demand educational fragmentation for 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; not experimental data.
Sources
Molecule identity
Retrieved 8/20/2026. Reuse status is summarized by the badge; open the source for full details.